GSK3B and hepatocellular carcinoma: Blocking GSK-3β phosphorylation and degradation by inactivating the PI3K/Akt axis, thereby inhibiting the Wnt/β-catenin signaling pathway and exerting inhibition of HCC cell proliferation and induction of apoptosis